US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Arch Therapeutics, Inc.

0.1608

0.0000

Volume:- -

Turnover:- -

Market Cap:714.66K

PE:-0.07

High:0.1608

Open:0.1608

Low:0.1608

Close:0.1608

52wk High:0.8400

52wk Low:0.1573

Shares:4.44M

Float Shares:4.30M

Volume Ratio:0.03

T/O Rate:- -

Dividend:- -

Dividend Rate:- -

EPS(TTM):-2.3462

EPS(LYR):-2.2715

ROE:-4014.80%

ROA:-199.27%

PB:-0.06

PE(LYR):-0.07

Loading ...

Overview Company News Filings

Company Profile

Company Name:

Arch Therapeutics, Inc.

Exchange:

EXPERT

Establishment Date:

- -

Employees:

- -

Office Location:

- -

Website:

http://www.archtherapeutics.com

Zip Code:

- -

Phone:

- -

Fax:

- -

Introduction:

Arch Therapeutics, Inc., together with its subsidiaries, operates as a biotechnology company in the United States. It develops and markets products based on its AC5 self-assembling technology platform to stop bleeding and control leaking, as well as manages wounds during surgery, trauma, and interventional care or from disease. The company's flagship products include AC5 advanced wound system and AC5 topical hemostat, which are intended for skin applications, such as management of complicated chronic wounds or acute surgical wounds. It is also involved in the development of AC5-G for gastrointestinal endoscopic procedures, and AC5-V and AC5 surgical hemostat for hemostasis inside the body. The company was founded in 2006 and is based in Framingham, Massachusetts.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/ARTH/company"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ARTH","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ARTH\",,,,,undefined,":{"symbol":"ARTH","market":"US","secType":"STK","nameCN":"Arch Therapeutics, Inc.","latestPrice":0.1608,"timestamp":1756497600000,"preClose":0.1608,"halted":0,"volume":0,"delay":15,"floatShares":4297158,"shares":4444400,"eps":-2.346175,"marketStatus":"Closed Labor Day","change":0,"latestTime":"08-29 16:00:00 EDT Delay","open":0.1608,"high":0.1608,"low":0.1608,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":-2.346175,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1756800000000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"EXPERT","adjPreClose":0.1608,"volumeRatio":0.028958359685171516},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ARTH\",,,,,undefined,":{"symbol":"ARTH","floatShares":4297158,"roa":"-199.27%","roe":"-4014.80%","lyrEps":-2.271494,"volumeRatio":0.028958359685171516,"shares":4444400,"dividePrice":0,"high":0.1608,"amplitude":0,"preClose":0.1608,"low":0.1608,"week52Low":0.1573,"pbRate":"-0.06","psRate":"4.82","week52High":0.84,"institutionHeld":0,"latestPrice":0.1608,"eps":-2.346175,"divideRate":0,"volume":0,"delay":15,"ttmEps":-2.346175,"open":0.1608,"prevYearClose":0.17,"prevWeekClose":0.1608,"prevMonthClose":0.1608,"prevQuarterClose":0.1608,"fiveDayClose":0.1608,"twentyDayClose":0.1608,"sixtyDayClose":0.1608},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ARTH\",params:#limit:5,,,undefined,":[{"market":"US","date":"2024-08-19","symbol":"ARTH","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1724040000000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2024-05-09","symbol":"ARTH","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1715227200000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2024-02-20","symbol":"ARTH","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1708405200000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2023-08-11","symbol":"ARTH","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1691726400000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2023-01-18","symbol":"ARTH","defaultRemindTime":1674052200000,"type":"split","dateTimestamp":1674018000000,"forFactor":200,"toFactor":1,"ratio":200}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ARTH\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ARTH\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"websiteUrl":"http://www.archtherapeutics.com","stockEarnings":[{"period":"1week","weight":-0.0078},{"period":"1month","weight":-0.1321},{"period":"3month","weight":-0.2698},{"period":"6month","weight":-0.3784},{"period":"1year","weight":-0.3867},{"period":"ytd","weight":-0.566}],"description":"Arch Therapeutics, Inc., together with its subsidiaries, operates as a biotechnology company in the United States. It develops and markets products based on its AC5 self-assembling technology platform to stop bleeding and control leaking, as well as manages wounds during surgery, trauma, and interventional care or from disease. The company's flagship products include AC5 advanced wound system and AC5 topical hemostat, which are intended for skin applications, such as management of complicated chronic wounds or acute surgical wounds. It is also involved in the development of AC5-G for gastrointestinal endoscopic procedures, and AC5-V and AC5 surgical hemostat for hemostasis inside the body. The company was founded in 2006 and is based in Framingham, Massachusetts.","exchange":"EXPERT","name":"Arch Therapeutics, Inc.","nameEN":"Arch Therapeutics, Inc."}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"ARTH\",market:\"US\",,,undefined,":null}}